FDA-approved brand-name medications are prescribed when appropriate, with compounded options available through licensed 503A pharmacies
Assistance with medication management, healthy routines, physical activity, and social engagement can help protect quality of life and independence
For example, someone with severe gastroparesis or a history of vomiting with any medication might find PT-141 intolerable
Because of the limited glucose-lowering potential of DPP-4 inhibitors, metformin with a DPP-4 inhibitor in patients with baseline A1C 10% will not get most patients to their goal
Researchers use Lipo C to investigate fat utilization, liver detoxification, and metabolic signaling pathways involved in lipid breakdown and energy regulation
Dose adjustment considerations: If gastrointestinal symptoms are severe or persistent despite these measures, contact your prescribing clinician to discuss: Slowing the dose escalation schedule Temporarily reducing the dose Taking a brief treatment pause (though this may affect weight loss progress) Switching to an alternative weight management medication if symptoms are intolerable The STEP trials demonstrated that slower dose titration can reduce the incidence and severity of gastrointestinal adverse effects